BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Sielaff CM, Mousa SA. Status and future directions in the management of pancreatic cancer: potential impact of nanotechnology. J Cancer Res Clin Oncol 2018;144:1205-17. [PMID: 29721665 DOI: 10.1007/s00432-018-2651-3] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.8] [Reference Citation Analysis]
Number Citing Articles
1 Ash GI, Kim D, Choudhury M. Promises of Nanotherapeutics in Obesity. Trends Endocrinol Metab 2019;30:369-83. [PMID: 31126754 DOI: 10.1016/j.tem.2019.04.004] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
2 Ghanbari-Movahed M, Kaceli T, Mondal A, Farzaei MH, Bishayee A. Recent Advances in Improved Anticancer Efficacies of Camptothecin Nano-Formulations: A Systematic Review. Biomedicines 2021;9:480. [PMID: 33925750 DOI: 10.3390/biomedicines9050480] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
3 Vodyashkin AA, Rizk MGH, Kezimana P, Kirichuk AA, Stanishevskiy YM. Application of Gold Nanoparticle-Based Materials in Cancer Therapy and Diagnostics. ChemEngineering 2021;5:69. [DOI: 10.3390/chemengineering5040069] [Cited by in Crossref: 2] [Article Influence: 2.0] [Reference Citation Analysis]
4 Xu S, Xu H, Wang W, Li S, Li H, Li T, Zhang W, Yu X, Liu L. The role of collagen in cancer: from bench to bedside. J Transl Med 2019;17:309. [PMID: 31521169 DOI: 10.1186/s12967-019-2058-1] [Cited by in Crossref: 116] [Cited by in F6Publishing: 122] [Article Influence: 38.7] [Reference Citation Analysis]
5 Rebelo A, Reis C. Emerging therapeutic nanotechnologies in pancreatic cancer: advances, risks and challenges. Ther Deliv 2018;9:691-4. [PMID: 30277137 DOI: 10.4155/tde-2018-0048] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
6 Guo F, Li J, Qi Y, Hou J, Chen H, Jiang SW. HE4 overexpression decreases pancreatic cancer Capan-1 cell sensitivity to paclitaxel via cell cycle regulation. Cancer Cell Int 2020;20:163. [PMID: 32435154 DOI: 10.1186/s12935-020-01248-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]